Viomycin-resistant strains isolated from Mycobacterium smegmatis demonstrated pleiotropic resistance to tuberactinomycin-N, capreomycin, streptomycin, and kanamycin as a result of mutational alteration of ribosomes, even though they were selected for resistance to a single antibiotic. The pleiotropic drug resistance of three mutants isolated by stepwise selection for resistance to viomycin was due to alteration of the 30S ribosomal subunit. One mutant, strain A, isolated independently by multiple-step selection to viomycin resistance, was resistant to viomycin, tuberactinomycin-N, and capreomycin through an alteration of the 50S ribosomal subunit, whereas it was sensitive to kanamycin but resistant to streptomycin through an alteration of the 30S ribosomal subunit. Three streptomycin-resistant strains, which were isolated by one-step selection at a high concentration of streptomycin, did not show significant co-resistance to any other antibiotics tested in culture and cell-free systems; streptomycin resistance in these mutants was localized on the 30S ribosomal subunit.
Pleiotropic drug resistance associated with viomycin (VM) resistance in mycobacteria has been reported (6, 9, 12, 13, 14, 15, 25, 26, 31, 32, 33, 34, 37, 38, 39) . Three possible mechanisms for this drug resistance might be considered: (i) enzymatic inactivation of the drugs (17) , (ii) alteration of the membrane leading to a change in permeability, and (iii) alterations at the site of action of the antibiotics, e.g., ribosomes (44) .
As a continuation of our work, pleiotropic drug resistance was studied in culture and in cell-free systems. The results indicate that mutational alteration of the VM binding site on ribosomes led to pleiotropic drug resistance in Mycobacterium smegmatis.
The results were presented in abstract form at the XXIInd International Tuberculosis Conference (T. Yamada et al., XXIInd Int. Tuberc. Conf., Tokyo, abstract, p. 25, 1973) . Strains and culture medium. M. smegmatis ATCC 14468 and E. coli A 19 (ribonuclease I-), as described in a previous paper (44) , were used. All culture media have been described previously (44) .
Isolation of VM-resistant strains by one-step selection and replica-plate method. M. smegmatis was grown on the surface of glycerol agar medium at 37 C for 4 Ribosomes and supernatant fluid. Ribosomes, ribosomal subunits, and supernatant fluid were prepared as described previously (42) .
Cell-free system. Experimental conditions for poly (U)-directed polyphenylalanine synthesis were as described previously (16, 42 Table 1 that strain 0-1 is co-resistant to high levels of TUM, CPRM, SM, and KM. In cell-free systems, ribosomes of strain 0-1 were also co-resistant to these antibiotics but the supernatant fractions were not (unpublished data). Ribosomal subunits were isolated from the parent and resistant strains and were reconstructed in vitro to give normal and hybrid ribosomes, and the antibiotic sensitivity of these were tested in the cell-free system.
From Tables 2-6 it is clear that co-resistance to these antibiotics was localized on 30S ribosomal subunits. ently isolated mutants, E and M, were tested for their degree of resistance to each antibiotic in culture. The degree of co-resistance of strain E to the aminoglycoside antibiotics did not parallel that of VM, whereas the level of coresistance to VM, TUM, and CPRM was approximately similar (Table 1) . Thus, strain E was resistant to SM at a low level and to KM at high levels. On the contrary, strain M was resistant to both KM and SM (more than 2,000
,ug/ml) and to CPRM (1,000 ug/ml) at high levels.
As shown in Table 7 , analysis of these strains in cell-free, polypeptide-synthesizing systems showed that co-resistance in both strains was localized on the 30S ribosomal subunits.
Characterization of strain A of M. smegmatis. It has been reported previously (44) that high-level VM resistance of M. smegmatis strain A was due to an alteration of the 50S ribosomal subunits (44) . Therefore, it was of interest to examine the subunit localization of the co-resistance of these mutants in the cellfree system. Strain A was sensitive to KM but resistant to high levels of VM, CPRM, TUM, and SM in culture (Table 1 ).
Resistance to TUM and CPRM in strain A was a property of the 50S ribosomal subunit which coincides with the localization of VM resistance (Table 8) . By contrast, resistance to SM was associated with the 30S ribosomal subunit as shown in Table 9 . Since strain A was isolated by multiple-step selection, we consider that the localization of SM and VM resistance on different subunits arose through mutational alteration of the 30S ribosomal subunit, resulting in very low-level resistance to VM which was selected in one step. The degree of VM resistance, but not the associated SM resistance, might have been too low to detect in the cell-free system.
Analysis of streptomycin-resistant mutants of M. smegmatis. Three streptomycinresistant mutants which were isolated independently by one-step selection were tested for sensitivity to VM, TUM, CPRM, and KM. None of these isolates gave significant increases of resistance to any other antibiotics tested (Table 1) .
In a cell-free system, resistance of mutants KS, K-1, and K-2 to SM could be localized on the 30S ribosomal subunits (Table 10) . DISCUSSION Antibiotic-resistant mutants of M. smegmatis, which by a single mutational event acquire pleiotropic low level drug resistance to VM, TUM, CPRM, SM, and KM, have been isolated. To isolate mutants with high level resist- ance to VM, multiple-step selection on VM was necessary. The observations suggest that multiple alterations in or near the VM binding site on ribosomes would create high level resistance to various antibiotics.
Analysis of strains 0-1, E, and M showed that pleiotropic drug resistance was due to alteration of the 30S ribosomal subunits. However, the comparison of levels of resistance showed that there was significant variation between different mutants in culture. The degree of resistance to VM and TUM was similar but different from that of resistance to SM, KM, and CPRM (Table 1 ). These observations suggest that the site of alteration of 30S ribosomal subunits in the VM-resistant mutants might be different from the binding site for CPRM (5) and aminoglycoside antibiotics, which involves the 30S ribosomal proteins (S12) specified by the str A gene in E. coli (19) ; the change in the VM binding site might induce a concomitant conformational change in the CPRM and aminoglycoside binding site which varies depending on the particular mutant.
Strain A was also a multiple-step resistant mutant. Whereas resistance to VM, TUM, and CPRM in this strain was localized on the 50S ribosomal subunit, resistance to SM was due to alteration of the 30S ribosomal subunit. This suggests that the peptide antibiotics might act on both subunits. Therefore, mutational alteration of either the 30S or 50S ribosomal subunit might produce mutants resistant to these antibiotics, and also the response of either subunit to peptide antibiotics could be modified by reassociation with altered subunits to 70S ribosomes. The levels of resistance on 30S ribosomal subunits to the peptide antibiotics, which might be associated with resistance to SM, was too low to allow any definite conclusions. 
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The subunit localization and the levels of resistance to SM and VM led us to analyze SM-resistant mutants selected against high concentrations of SM. Three high level SMresistant mutants were sensitive to VM, TUM, CPRM, and KM in culture and in cell-free systems. This observation suggests that the locus of VM resistance might be different from that of SM resistance on 30S ribosomal subunits, but alteration of the locus of VM resist- ance might give some functional effect to the site of SM resistance. The mode of action of VM and SM has been compared (7, 28) . In cell-free systems of E. coli, SM caused misreading whereas VM did not. The different mode of action of these antibiotics would be expected from the results obtained above.
Similar phenomena which suggest certain functional relationships between chloramphenicol and erythromycin binding sites has been reported (18, 27, 29, 30, 36, 40) . It has been reported and summarized in several studies that ribosomes often show alteration in their response to antibiotics when selection has been carried out by unrelated antibiotics (1, 2, 4, 21 ). VOL. 6, 1974 Resistance to SM has been studied in various organisms. In E. coli, three possible mechanisms have been proposed: (i) an alteration of the 30S ribosomal protein specified by the str A gene (19) , (ii) an alteration in permeability to SM specified by the str B gene (22) , and (iii) enzymatic inactivation of SM by adenylylation or phosphorylation (3, 20, 35, 43, 45) . In Salmonella typhimurium, two possible mechanisms have been shown: (i) an alteration of ribosomes specified by the str A gene (23, 41) and (ii) an alteration in permeability to SM specified by the str B gene (23, 41) . In Bacillus subtilis, alteration of ribosomes appears to be the only mechanism of resistance to SM thus far reported (8, 10, 11, 24) .
In M. smegmatis, two possible mechanisms can now be proposed: (i) an alteration of 30S ribosomal subunits which might be analogous to the ribosomal alteration specified by the str A gene in E. coli, and (ii) an alteration of 30S ribosomal subunits which might be conferred by the VM-resistance locus.
Some genetic analysis of mutant A of M. smegmatis has been carried out. Preliminary results suggested that genetic loci for VM were multiple and some of them were linked to arg B on the M. smegmatis chromosome (Mizuguchi et al., submitted for publication). The details of genetic compositions of each mutant will be published later.
